FTH
Faeth Therapeutics, Inc
FTH
Closed
$35.79
Closed
-(-)
At close
Get professional financial guidance
Schedule your free first call with a financial advisor on CUSP Wealth
*T&Cs apply
About
Sensei Biotherapeutics, Inc. is a clinical-stage biopharmaceutical company which focuses on the discovery, development, and delivery of next generation immunotherapies for the treatment of cancer and infectious diseases. The company is headquartered in Austin, Texas and currently employs 29 full-time employees. The company went IPO on 2021-02-04. The firm's lead program is PIKTOR, an investigational all-oral combination of serabelisib and sapanisertib in development for endometrial and breast cancer. PIKTOR engages three nodes simultaneously: PI3K-alpha upstream, mTORC1 and mTORC2 downstream, simultaneously. PIKTOR is designed to deliver multi-node pathway inhibition in an oral formulation. Its pipelines include PIKTOR (PIK-201), PIKTOR (PIK-101) and Sapanisertib.
Key stats
Open
$36.56
Volume
209.36K
Market cap
$913.98M
Prev. close
$35.36
Impl / hst vl
-
Open interest
$0.00
$35.11
Day’s Range
$37.44
$8.37
52W Range
$42.14
Valuation
Analysts estimates
Consensus rating
Buy
The average rating from top 8 analysts indicates that stock is expected to perform in line with the market
Str. Sell
Sell
Hold
Buy
Str. Buy
Avg. price target
$56.20
The top 11 analysts forecasts that 12-month price may increase by 57.03%, with a low of $46.46 and a high of $63.00
$46.46
Low
$56.20
Avg
$63.00
High
Current price
Earnings
Q2 ‘26 revenue
$0.00
Q2 ‘26 net income
-$16.01M
Revenue
Net income
Previous EPS
-$28.79
Estimate EPS
-$3.08
Actual EPS
Estimate EPS
Get professional financial guidance
Schedule your free first call with a financial advisor on CUSP Wealth
*T&Cs apply